Scientific Program

1. Special Guest Lecture:

Tuesday, September 13,13:30-14:30Concord ABC

Chairpersons: Akira Iritani (Japan)

13:30-14:30Induction of pluripotency by defined factorsShinya Yamanaka (Japan)

2. Opening Ceremony, Lecture and Welcome Reception:

Opening Ceremony:

Saturday, September 10,18:30-19:30Eminence Hall, 5F


Opening Ceremony
Opening Lecture

A tribute to Robert Edwards - the pioneer of human IVF

Victor Gomel (Canada)

Welcome Reception:

Saturday, September 10,19:30-21:30Concord ABC, 5F

3. Plenary Sessions:

Sunday, September 11,8:30-10:00Concord ABC

Chairperson: Victor Gomel (Canada)

8:30-8:50 Plenary -1 (1) Advances in natural and mild stimulation cycle IVF - progress over the last 15 years Osamu Kato (Japan)

Chairperson: Victor Gomel (Canada)

8:50-9:00 Plenary -1 (2) Clomid® ovarian stimulation for IVF and frozen ET
John Zhang (USA)

Chairperson: Sherman Silber (Japan)

9:00-9:00 Plenary -2 Non-invasive assessment of embryo quality Zsolt Peter Nagy (USA)

Chairperson: Takahide Mori (Japan)

9:30-10:00 Plenary -3
The prospect of embryonic stem cell research Shin Yong Moon (Korea)

Monday, September 12,8:30-10:00Concord ABC

Chairperson: Atsushi Tanaka (Japan)

8:30-9:00 Plenary -4 Pre-implantation genetic diagnosis: an update Alan Handyside (UK)

Chairperson: Chii-Ruey Tzeng (Taiwan)

9:00-9:30 Plenary -5 Preservation of fertility Sherman Silber (USA)

Chairperson: Shuetsu Suzuki (Japan)

9:30-10:00 Plenary -6 The role of reproductive surgery in the era of IVF&ART Victor Gomel (Canada)

Tuesday, September 13,8:30-10:00Concord ABC

Chairperson: Yoon-Seok Chang (Korea)

8:30-9:00 Plenary -7 Recent advance of controlled ovarian stimulation Klaus Diedrich (Germany)

Chairperson: Hiroshi Okada (Japan)

9:00-9:30 Plenary -8 Tending to male factor couples Gianpiero D. Palermo (USA)

Chairperson: Yoshiharu Morimoto (Japan)

9:30-10:00 Plenary -9 IVM for fertility treatment and preservation of
Seang Lin Tan (Canada)

4. Pre-Congress Workshops:

1) Vitrification

Saturday, September 10,9:00-12:00Hana A

Chairpersons: Stanley Leibo (USA), Masashige Kuwayama (Japan)

(1) Lectures
1. Basic science of vitrificationStanley Leibo (USA)
2. Ovarian reserving (basic research)Noriko Kagawa (Japan)
3. Ovary Transplant: Ovary allotransplantation between
non-hemozygeous sisters: Success and failure,
an immunologic puzzle
Sherman Silber (USA)
(2) Live demonstration
4. The Cryotop® methodMasashige Kuwayama (Japan)

2) Pre-implantation genetic diagnosis (PGD)

Saturday, September 10,14:00-17:00Hana A

Chairpersons: Naoki Aoyama (Japan), Ilan Tur-Kaspa (USA)

(1) Lectures
1. OverviewKou Sueoka (Japan)
2. Whole genome amplification is a new basic technology for
next-generation preimplantation genetic diagnosis on
mendelian inheritance disease
Suguru Sato (Japan)
3. To PGD or not to PGD? How many oocytes are needed to
start PGD with?
Ilan Tur-Kaspa (USA)
(2) Live demonstration
4. Efficient techniques of PGD for recurrent pregnancy loss (Live)Naoki Aoyama (Japan)

5. Concurrent Symposia:

C-1 Management of PCO patients (1)

Sunday, September 11,10:30-11:50Concord A

Chairpersons: Timur Gürgan (Turkey), Makio Shozu (Japan)

10:30-10:50 1. Androgenic spectrum concept of PCO morphogenesisTakahide Mori (Japan)
10:50-11:10 2. Do phenotypic differences in PCOS affect fertility treatment
and outcomes?
Rogerio A. Lobo (USA)
11:10-11:30 3. Laser assisted ICSI for oocytes matured in vitro from PCO
Muchsin Jaffar (Indonesia)
11:30-11:50 4. The use of GnRH antagonist in the controlled ovarian
stimulation for IVF in PCOS patients
Khaled Mahmoud (Tunisia)

C-2 Management of PCO Patients (2)

Sunday, September 11,13:20-15:00Concord A

Chairpersons: Rogerio A. Lobo (USA), Khaled Mahmoud (Tunisia)

13:20-13:40 1. Polycystic ovary syndrome is associated with metabolic
abnormalities in the purine mononucleotide pathway and
tricarboxylic acid cycle
Makio Shozu (Japan)
13:40-14:00 2. How to get pregnancy in women with PCOSChii-Ruey Tzeng (Taiwan)
14:00-14:20 3. ART Management in PCOToshiro Kubota (Japan)
14:20-14:40 4. PCO and ovarian drillingTimur Gürgan (Turkey)
14:40-15:00 5. PCO and transvaginal hydrolaparoscopic ovarian drilling
Hiroaki Shibahara (Japan)

C-3 Controlled ovarian stimulation (1)

Sunday, September 11,15:20-16:40Concord A

Chairpersons: Bruno Lunenfeld (Israel),TBA (Japan)

15:20-15:40 1. Available tools to personalize ovarian stimulation - Dose
prediction/protocol selection
Bruno Lunenfeld (Israel)
15:40-16:00 2. Advances in ultrasound monitoring of IVF cycles
by automated volume measurment
Baris Ata (Canada)
16:00-16:20 3. Volmetric measurements of the follicular developmentMaximilian Murtinger (Austria)
16:20-16:40 4. Ovarian stimulation and endometrial receptivityPak-Chung Ho (Hong Kong)

C-3 Controlled ovarian stimulation (2)

Sunday, September 11,16:40-18:00Concord A

Chairpersons: Svend Lindenberg (Denmark), Minoru Irahara (Japan)

16:40-17:00 5. Minimal ovarian stimulation (mini-IVF) for IVF utilizing
vitrification and cryopreserved embryo transfer
John Zhang (USA)
17:00-17:20 6. Poor responder patients undergoing IVF treatmentSvend Lindenberg (Denmark)
17:20-17:40 7. Prediction and prevention of the ovarian hyperstimulation
syndrome (OHSS) - an evidence-based approach
Hassan Sallam (Egypt)
17:40-18:00 8. What should we prefer for IVF - the agonist or antagonist?Zion Ben-Rafael (Israel)

C-4 Treatment of benign tumor prior to IVF-ET (1)

Sunday, September 11,10:30-11:50Concord B

Chairpersons: Zion Ben-Rafael (Israel), Hassan Sallam (Egypt)

10:30-10:50 1. Evidence-based management of endometriosis-associated
Hassan Sallam (Egypt)
10:50-11:10 2. Surgery of endometriosis in infertility: state of the art !Issam Lebbi (Tunisia)
11:10-11:30 3. Surgical management of recurrent endometrioma:
prior to IVF or not
Hiroshi Nabeshima (Japan)
11:30-11:50 4. Management of hydrosalpinges prior to IVF-ETVictor Gomel (Canada)

C-5 Treatment of uterine myoma or adenomyosis prior to IVF-ET (2)

Sunday, September 11,13:20-15:00Concord B

Chairpersons: Victor Gomel (Canada), Issam Lebbi (Tunisia)

13:20-13:40 1. Surgery of intra-mural leiomyomas in infertile patientsJean-Bernard Dubuisson (Switzerland)
13:40-14:00 2. Myomectomy during pregnancyYuji Hiramatsu (Japan)
14:00-14:20 3. Uterine fibroids and IVF- what is the controversy?Zion Ben-Rafael (Israel)
14:20-14:40 4. A novel operative treatment of severe adenomyosis
prior to embryo transfer
Hisao Osada (Japan)
14:40-15:00 5. Different surgical approaches for myomectomy and for
Michael DeRosa (USA)

C-6 Oncofertility - fertility preservation in women with malignant disease (1)

Sunday, September 11,15:20-16:40Concord B

Chairpersons: Claus Yding Andersen (Denmark), Takeshi Maruo (Japan)

15:20-15:40 1. The oncofertility: consequences of a previous
oncological treatments and possibilities
Rufino Garcia-Otero Reina (Spain)
15:40-16:00 2. Fertility Sparing in Stage Ia2 to Ib1-Cervix CarcinomaWerner Lichtenegger (Germany)
16:00-16:20 3. Abdominal radical trachelectomy in our experience of 126
Takuma Fujii (Japan)
16:20-16:40 4. Laparoscopic radical trachelectomyMasaaki Ando (Japan)

C-7 Oncofertility - fertility preservation in women with malignant disease (2)

Sunday, September 11,16:40-18:00Concord B

Chairpersons: Klaus Diedrich (Germany), Kazunori Ochiai (Japan)

16:40-17:00 1. Cryopreservation of human oocyte for cancer patients
in Japan
Shokichi Teramoto (Japan)
17:00-17:20 2. Cryopreservation of human ovarian tissue, clinical data
and scientific considerations
Claus Yding Andersen (Denmark)
17:20-17:40 3. Conservative therapy for borderline ovarian cancerLiong Tulusan (Germany)
17:40-18:00 4. Infertility, ovulation induction treatments and the incidence
of breast, ovarian and endometrial cancers - thirty years of
follow up
Bruno Lunenfeld (Israel)

C-8 ART-cryopreservation: Is oocyte cryopreservation a revolution in IVF?

Sunday, September 11,10:30-11:50Concord C

Chairpersons: Stanley Leibo (USA), Masashige Kuwayama (Japan)

10:30-10:501. Highly efficient and safe vitrification using hydroxypropyl
cellulose as a macromolecular supplement for
cryopreservation of oocytes and blastocysts
Luis Arturo Ruvalcaba Castellón (Mexico)
10:50-11:102. Role and possibility of vitrification in human oocyteMasashige Kuwayama (Japan)
11:10-11:303. Blastulation and pregnancy rates after vitrified human
zygote culture for 4 days: Preliminary results
Safaa Al Hasani (Germany)
11:30-11:504. Cryopreservation in human ARTStanley Leibo (USA)

C-9 Children follow up in ART (1)

Sunday, September 11,13:20-14:40Concord C

Chairpersons: Fethi Zhioua (Tunisia), Osamu Ishihara (Japan)

13:20-13:401. Evaluate the IVF success rates of accumulated pregnancy
rates per oocyte retrieval
Jia-Yin Liu (China)
13:40-14:002. Genetics and health of children born from cryopreserved
Ilan Tur-Kaspa (USA)
14:00-14:20 3. What has happened on epigenetics in ART children?Yukiko Katagiri (Japan)
14:20-14:40 4. Pregnancy and child outcome after assisted reproductive
Dov Feldberg (Israel)

C-10 Children follow up in ART (2)

Sunday, September 11,15:00-16:20Concord C

Chairpersons: Hideaki Kanzaki (Japan), Dov Feldberg (Israel)

15:00-15:20 1. Just Twins? Perinatal data from multiple pregnanciesPeter Brockerhoff (Germany)
15:20-15:40 2. Perinatal outcomes of ART pregnanciesFethi Zhioua (Tunisia)
15:40-16:00 3. Outcome of IVM babiesRi-Cheng Chian (Canada)
16:00-16:20 4. Perinatal outcome of vitrified human blastocysts in 11 years
experience (5434 attempted cycles) including the rate of
monozygotic twinning (MZT)
Tetsunori Mukaida (Japan)

C-11 Laboratory advances in IVF (1)

Sunday, September 11,16:20-17:40Concord C

Chairpersons: Pierre Vanderzwalmen (Belgium), Gábor Vajta (Australia)

16:20-16:401. Novel embryo culturing and monitoring systems Artur Bernard (Hungary)
16:40-17:00 2. Effects of cumulus cells removal after 6 h co-incubation
of gametes on the outcomes of human IVF
Guoning Huang (China)
17:00-17:20 3. An integral view on therapeutic options and lab-techniques
for individualized therapy in IVF
Nicolas Zech (Austria)
17:20-17:40 4. How to manage the modern IVF laboratory Zsolt Peter Nagy (USA)

C-12 Laboratory advances in IVF (2)

Sunday, September 11,13:20-14:40Hana A

Chairpersons: Yoshihiko Hosoi (Japan), Zsolt Peter Nagy (USA)

13:20-13:40 1. Chemical substances exposure on IVF-ET environmentTsunehisa Makino (Japan)
13:40-14:00 2. Recent insights into the oocyte maturation in ARTTae-Ki Yoon (Korea)
14:00-14:20 3. Use of high concentrations of cryoprotectants: is it a
justified argument to prefer slow freezing instead of
Pierre Vanderzwalmen (Belgium)
14:20-14:40 4. Embryo culture: Can we perform better than Nature? Gábor Vajta (Australia) 

C-13 Controlled ovarian stimulation (3)

Monday, September 12,10:30-11:50Concord A

Chairpersons: Herbert Zech (Austria), Osamu Tsutsumi (Japan)

10:30-10:50 1. Superovulation/IUI - An Alternative to IVFBill Yee (USA)
10:50-11:10 2. Treatment of patients with high FSH with delayed
stimulation using low dose gonadotrophins
Milton Leong (Hong Kong)
11:10-11:30 3. Use of hCG in ovarian stimulationJohan Smitz (Belgium)
11:30-11:50 4. Follicle stimulation by transdermal application of FSHHerbert Zech (Austria)

C-14 Advances in basic research and laboratory techniques in IVM (1)

Monday, September 12,13:20-14:20Concord A

Chairpersons: Yoshiharu Morimoto (Japan), Ri-Cheng Chian (Canada)

13:20-13:401. IVM: learning from IVM ?Nelly A. Frydman (France)
13:40-14:00 2. Quality evaluation of human & mouse IVM embryo
and epigenetic evaluation of human born IVM babies
Hiroaki Yoshida (Japan)
13:20-13:403. Lessons from the mouse follicle culture and in vitro
maturation models
Johan Smitz (Belgium)

C-14 Advances in basic research and laboratory techniques in IVM (2)

Monday, September 12,14:20-15:20Concord A

Chairpersons: Jie Qiao (China), Hiroaki Yoshida (Japan)

14:20-14:40 4. Laboratory aspect of natural cycle IVF/ IVM treatmentRi-Cheng Chian (Canada)
14:40-15:00 5. Cytoplasmic maturation and mitochondrial activity
in human IVM
Yoshiharu Morimoto (Japan)
15:00-15:20 6. Correct embryo selection improves embryo implantation
rates in IVM cycles
Hai Ying Chen (Canada)

C-15 Clinical outcomes; toward a more successful IVM

Monday, September 12,15:40-17:20Concord A

Chairpersons: Johan Smitz (Belgium), Aisaku Fukuda (Japan)

15:40-16:00 1. IVM application in PCOS patients Jie Qiao (China)
16:00-16:20 2. Oocyte maturation from tiny follicles in human ovarian
Shu Hashimoto (Japan)
16:20-16:40 3. Natural cycle combined with IVMJin-Ho Lim (Korea)
16:40-17:00 4. The effective approach for IVM using Metformin Aisaku Fukuda (Japan)
17:00-17:20 5. Clinical implications of IVM Svend Lindenberg (Denmark)

C-16 Embryo development and competency from activation to implantation

Monday, September 12,10:30-12:10Concord B

Chairpersons: Jin-Ho Lim (Korea), Atsushi Azumaguchi (Japan)

10:30-10:50 1. Morphological aspectNelly A. Frydman (France)
10:50-11:10 2. Early embryo development: what's critical Moncef Benkhalifa (France)
11:10-11:303. Implantation window Atsushi Azumaguchi (Japan)
11:30-11:504. Luteal phase support Svend Lindenberg (Denmark)
11:50-12:105. Predictors of IVF outcome with a particular interest
in the mount of gonadotropin administered
Peter Kovacs (Hungary)

C-17 ART-Gamete manipulation

Monday, September 12,13:20-14:20Concord B

Chairpersons: Moncef Benkhalifa (France), Atsushi Tanaka (Japan)

13:20-13:401. Whole ooplasmic replacement in Germinal Vesicle
Akiko Yabuuchi (Japan)
13:40-14:002. Dynamic genome function and chromosomes abnormalitiesMoncef Benkhalifa (France)
14:00-14:203. A novel trial of nuclear transfer for repairing an aged oocyte Atsushi Tanaka (Japan)

C-18 Update on male infertility IMSI/ ICSI/ MD-TESE/ PGD

Monday, September 12,14:20-15:20Concord B

Chairpersons: Sherman Silber (USA), Hiroshi Okada (Japan)

14:20-14:40 1. Male infertility Sherman Silber (USA)
14:40-15:00 2. Microdissection Testicular Sperm Extraction(MD-TESE) Atsumi Yoshida (Japan)
15:00-15:20 3. IMSI, already 8 years in ART practice. Where do we stand?Pierre Vanderzwalmen (Belgium)

C-19 AMH: Is it essential for assessing ovarian reserve

Monday, September 12,10:30-11:50Concord C

Chairpersons: Bunpei Ishizuka (Japan), Hsin-Fu Chen (Taiwan)

10:30-10:50 1. Clinical application of AMH in the reproductive medicineYoshimasa Asada (Japan)
10:50-11:10 2. Chronological aging VS biological aging: AMH as an early
marker of biological aging
Budi Wiweko (Indonesia)
11:10-11:30 3. POF and AMHBunpei Ishizuka (Japan)
11:30-11:50 4. Dynamic serum AMH levels and AMH-related gene
expression in human ovarian follicles
Hsin-Fu Chen (Taiwan)

C-20 The role of ART in international development (1)

Monday, September 12,13:20-14:20Concord C

Chairpersons: Willem Ombelet (Belgium), Sheryl Vanderpoel (Switzerland)

13:20-13:40 1. Implantation of the fertility assistance program after the
Wenchuan earthquake in China
Shangwei Li (China)
13:40-14:00 2. Cross-border cryo-shipping of vitrified embryos (CCVE):
the newest ART success story
Gautam Allahbadia (India)
14:00-14:20 3. Cross-border reproductive care: exploitation or opportunity
in the global quest for a baby?
Daniel S. Seidman (Israel)
14:20-14:40 4. Oocyte donors: prevalence of genetic, infectious diseases
and others
Oriol Coll (Spain)

C-20 The role of ART in international development (2)

Monday, September 12,14:20-15:20Concord C

Chairpersons: Daniel Seidman (Israel), Tetsunori Mukaida (Japan)

14:40-15:00 5. Vouchers for health: A demand side output-based aid
approach to reproductive health services. A model to pay
for infertility services?
Claus Peter Janisch (Germany)
15:00-15:20 6. Global challenges and perspectives Sheryl Vanderpoel (Switzerland)
15:20-15:40 7. Affordable IVF: low cost IVF - The Arusha project Willem Ombelet (Belgium)

C-21 Repeated implantation failure: how to improve implantation in ART

Tuesday, September 13,10:30-11:50Concord A

Chairpersons: Kouichi Takakuwa (Japan), Yael Gonen (Israel)

10:30-10:50 1. How to improve implantation in ART: novel approachesYael Gonen (Israel)
10:50-11:10 2. Studies on the efficacy of immunotherapy using paternal
mononuclear cells for patients with infertility
Kouichi Takakuwa (Japan)
11:10-11:30 3. Improvement of implantation rates using autologous
peripheral blood mononuclear cells
Hiroshi Fujiwara (Japan)
11:30-11:50 4. Prevention of infertility in patients for the antiphospholipid
syndrome and deficiencies of natural anticoagulants
Moritoshi Seki (Japan)

C-22 Pre-implantation genetic screening: an update

Tuesday, September 13,10:30-11:50Concord B

Chairpersons: Hidekazu Saito (Japan), Jiaen Liu (China)

10:30-10:50 1. PGD for recurrent pregnancy lossAtsushi Tanaka (Japan)
10:50-11:10 2. Polar body analysis in clinical practice as compared to
pre-embryo morphology for selection of the best for transfer
Wilfried Feichtinger (Austria)
11:10-11:30 3. PGD outcome and alternatives for single gene disorderKou Sueoka (Japan)
11:30-11:50 4. Preimplantation genetic diagnosis for aneuploidy using
whole genome amplification and microarray comparative
genomic hybridization
Alan Handyside (UK)

C-23 Stem cell and fertility preservation: Where are we at with stem cells?

Tuesday, September 13,10:30-12:10Concord C

Chairpersons: Kwang Yul Cha (Korea), Oktay Kadayifci (Turkey)

10:30-10:50 1. Human ES cell and iPS cell derivation: Clinical applications
and biological characterization
Hidenori Akutsu (Japan)
10:50-11:10 2. Pluripotent stem cell as a source of germ cells - Is it still
a fiction?
Anis Feki (Switzerland)
11:10-11:30 3. Development of pluripotent stem cells to female germ cellsHsin-Fu Chen (Taiwan)
11:30-11:50 4. Testicular stem cells as sources of fertility preservation
and cell therapy
Kwang Yul Cha (Korea)
11:50-12:10 5. In vitro production of functional sperm in cultured neonatal
mouse testes
Takehiko Ogawa (Japan)

6. STGO Session (Tunisian Society of Gynecology and Obstetrics)

(Coordinators: Khaled Mahmoud, Fethi Zhioua, Issam Lebbi)

Challenging issues in ART (1)

Monday, September 12,16:00-17:00Concord C

Chairpersons: Hedi Khairi, Anis Feki, Said Lazrak

16:00-16:20 1. How to manage hyper-response to COS in IVFYoussef Boutaleb (Morocco)
16:20-16:40 2. How to manage poor-responders?René Frydman (France)
16:40-17:00 3. The thin endometrium in ART: What to do? Amina Oumziane (Algeria)

Challenging issues in ART (2)

Monday, September 12,17:00-18:00Concord C

Chairpersons: Mahmoud Kharouf, Moise Fiadjoe, Nabil Ben Zineb

17:00-17:20 1. How to treat the female causes of repeated implantation
Khaled Terras (Tunisia)
17:20-17:40 2. How to manage sperm investigation after ICSI Failure?Moncef Benkhalifa (France)
17:40-18:00 3. How to improve laboratory procedures to enhance
Merdassi Ghaya (Tunisia)

7. ISF Session by the Israeli Society of Fertility

Monday, September 12,15:40-17:40Concord B

(Coordinator: Daniel Seidman)
Chairpersons: Arye Hurwitz, Martha Dirnfeld

15:40-16:00 1. Fertility enhancement in patients with adenomyosis using
MRI guided HIFUS
Yaron Rabinovici (Israel)
16:00-16:20 2. Gonadotropin-releasing hormone agonist trigger:
the way to eliminate OHSS
Arye Hurwitz (Israel)
16:20-16:40 3. From endometrial injury to IMSI: New approaches for
repeated IVF failure
Martha Dirnfeld (Israel)
16:40-17:00 4. High ART success rates when financial constraints are
completely lifted
Daniel Seidman (Israel)
17:00-17:20 5. Autologous transplantation of very thin ovarian fragments
which preserve the ovary's main cortex structure lead to
successful pregnancy
Ariel Revel (Israel)
17:20-17:40 6. How should we consult candidates for fertility
preservation due to a malignant disease regarding
their expected ovarian response to COH?
Shevach Friedler (Israel)

8. APART Session: MSCs - From basic research to clinical applications

Monday, September 12,13:20-15:00Hana A

Chairpersons: Yuji Takehara (Japan), Byung-Rok Do (Korea)

13:20-13:40 1. Clinical efficacy of adipose MSCs in human Byung-Rok Do (Korea)
13:40-14:00 2. Human lipoaspiration Ken Nakama (Japan)
14:00-14:20 3. Vitrification of adipose MSCs Noriko Kagawa (Japan)
14:20-14:40 4. Preparation of adipose-derived stem cells Rie Yamadera (Japan)
14:40-15:00 5. Discussion about clinical applications of adipose MSCs Yuji Takehara (Japan)

9. Oral communications

Click here for details

10. Poster Sessions

Poster viewing time (Hana B C D)

Sunday, September 11,10:00-10:30, 13:00-13:20Hana B C D

Monday, September 12,10:00-10:30, 13:00-13:20Hana B C D

Click here for details

11. Luncheon Seminars

Luncheon Seminar 1Sunday, September 11,12:00-13:00Concord A

Chairperson: Takafumi Utsunomiya (Japan)

12:00-13:00 GnRH antagonists in ovarian stimulation for IVF and
ICSI from practical perspective
Atsushi Tanaka (Japan)

Luncheon Seminar 2Sunday, September 11,12:00-13:00Concord B

Chairperson: Osamu Ishihara (Japan)

12:00-13:00 Clinical aspects of GnRH analogue use in Assisted
Naoaki Kuji (Japan)

Luncheon Seminar 3Sunday, September 11,12:00-13:00Concord C

Chairperson: Fumihito Aono

12:00-12:20 1. TBATeruhiko Wakayama (Japan)
12:20-12:40 2. TBAHiroshi Morita (Japan)
12:40-13:00 3. TBAAkiko Yabuuchi (Japan)

Luncheon Seminar 4Monday, September 12,12:00-13:00Concord A

Chairperson: Yoshiharu Morimoto (Japan)

12:00-13:00The role of AMH in female reproduction Budi Wiweko (Indonesia)

Luncheon Seminar 5Monday, September 12,12:00-13:00Concord C

Chairperson: Yuji Takehara

12:00-13:00 Fertility tourism in the U.S.John Zhang (USA)

>> back to top